Global Vesicular Stomatitis (VS) Therapeutics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Vesicular Stomatitis (VS) Therapeutics market size will reach US$ million by 2031.
Vesicular stomatitis is a zoonotic viral disease that primarily affects equines, cattle and swine. The virus can also infect sheep and goats as well as wildlife.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Vesicular Stomatitis (VS) Therapeutics Industry Forecast” looks at past sales and reviews total world Vesicular Stomatitis (VS) Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Vesicular Stomatitis (VS) Therapeutics sales for 2025 through 2031. With Vesicular Stomatitis (VS) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vesicular Stomatitis (VS) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Vesicular Stomatitis (VS) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vesicular Stomatitis (VS) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vesicular Stomatitis (VS) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vesicular Stomatitis (VS) Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vesicular Stomatitis (VS) Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Vesicular Stomatitis (VS) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Vesicular stomatitis is a zoonotic viral disease that primarily affects equines, cattle and swine. The virus can also infect sheep and goats as well as wildlife.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Vesicular Stomatitis (VS) Therapeutics Industry Forecast” looks at past sales and reviews total world Vesicular Stomatitis (VS) Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Vesicular Stomatitis (VS) Therapeutics sales for 2025 through 2031. With Vesicular Stomatitis (VS) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vesicular Stomatitis (VS) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Vesicular Stomatitis (VS) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vesicular Stomatitis (VS) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vesicular Stomatitis (VS) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vesicular Stomatitis (VS) Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vesicular Stomatitis (VS) Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Vesicular Stomatitis (VS) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Symptomatic Medications
- Vaccination
- Veterinary Hospitals
- Veterinary Clinics
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Merck & Co
- Zoetis
- Vedco
- Elanco
- Ceva Sant? Animale
- Vibrac
- Vetoquinol
- IDEXX Laboratories
- Covetrus
- Neogen
- Grand Pharmaceutical Group
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
2.1.2 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Vesicular Stomatitis (VS) Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Vesicular Stomatitis (VS) Therapeutics Segment by Type
2.2.1 Symptomatic Medications
2.2.2 Vaccination
2.3 Vesicular Stomatitis (VS) Therapeutics Market Size by Type
2.3.1 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Vesicular Stomatitis (VS) Therapeutics Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Retail Pharmacies
2.5 Vesicular Stomatitis (VS) Therapeutics Market Size by Application
2.5.1 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
3 VESICULAR STOMATITIS (VS) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Player
3.1.1 Global Vesicular Stomatitis (VS) Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Vesicular Stomatitis (VS) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VESICULAR STOMATITIS (VS) THERAPEUTICS BY REGION
4.1 Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025)
4.2 Global Vesicular Stomatitis (VS) Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2020-2025)
4.4 APAC Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2020-2025)
4.5 Europe Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
5.2 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025)
5.3 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025)
6.2 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025)
6.3 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
7.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025)
7.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VESICULAR STOMATITIS (VS) THERAPEUTICS MARKET FORECAST
10.1 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.3 APAC Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.4 Europe Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Forecast
10.2 Americas Vesicular Stomatitis (VS) Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.2.2 Canada Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.2.3 Mexico Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.2.4 Brazil Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3 APAC Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2026-2031)
10.3.1 China Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.2 Japan Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3.3 Korea Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3.4 Southeast Asia Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3.5 India Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3.6 Australia Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4 Europe Vesicular Stomatitis (VS) Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4.2 France Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4.3 UK Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4.4 Italy Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4.5 Russia Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.5.2 South Africa Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.5.3 Israel Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.5.4 Turkey Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.6 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Type (2026-2031)
10.7 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Vesicular Stomatitis (VS) Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Information
11.1.2 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product Offered
11.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Boehringer Ingelheim Main Business Overview
11.1.5 Boehringer Ingelheim Latest Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Vesicular Stomatitis (VS) Therapeutics Product Offered
11.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Merck & Co Main Business Overview
11.2.5 Merck & Co Latest Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Vesicular Stomatitis (VS) Therapeutics Product Offered
11.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Zoetis Main Business Overview
11.3.5 Zoetis Latest Developments
11.4 Vedco
11.4.1 Vedco Company Information
11.4.2 Vedco Vesicular Stomatitis (VS) Therapeutics Product Offered
11.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Vedco Main Business Overview
11.4.5 Vedco Latest Developments
11.5 Elanco
11.5.1 Elanco Company Information
11.5.2 Elanco Vesicular Stomatitis (VS) Therapeutics Product Offered
11.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Elanco Main Business Overview
11.5.5 Elanco Latest Developments
11.6 Ceva Sant? Animale
11.6.1 Ceva Sant? Animale Company Information
11.6.2 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Product Offered
11.6.3 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Ceva Sant? Animale Main Business Overview
11.6.5 Ceva Sant? Animale Latest Developments
11.7 Vibrac
11.7.1 Vibrac Company Information
11.7.2 Vibrac Vesicular Stomatitis (VS) Therapeutics Product Offered
11.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Vibrac Main Business Overview
11.7.5 Vibrac Latest Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Company Information
11.8.2 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product Offered
11.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Vetoquinol Main Business Overview
11.8.5 Vetoquinol Latest Developments
11.9 IDEXX Laboratories
11.9.1 IDEXX Laboratories Company Information
11.9.2 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product Offered
11.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 IDEXX Laboratories Main Business Overview
11.9.5 IDEXX Laboratories Latest Developments
11.10 Covetrus
11.10.1 Covetrus Company Information
11.10.2 Covetrus Vesicular Stomatitis (VS) Therapeutics Product Offered
11.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Covetrus Main Business Overview
11.10.5 Covetrus Latest Developments
11.11 Neogen
11.11.1 Neogen Company Information
11.11.2 Neogen Vesicular Stomatitis (VS) Therapeutics Product Offered
11.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Neogen Main Business Overview
11.11.5 Neogen Latest Developments
11.12 Grand Pharmaceutical Group
11.12.1 Grand Pharmaceutical Group Company Information
11.12.2 Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Product Offered
11.12.3 Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Grand Pharmaceutical Group Main Business Overview
11.12.5 Grand Pharmaceutical Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
2.1.2 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Vesicular Stomatitis (VS) Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Vesicular Stomatitis (VS) Therapeutics Segment by Type
2.2.1 Symptomatic Medications
2.2.2 Vaccination
2.3 Vesicular Stomatitis (VS) Therapeutics Market Size by Type
2.3.1 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Vesicular Stomatitis (VS) Therapeutics Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Retail Pharmacies
2.5 Vesicular Stomatitis (VS) Therapeutics Market Size by Application
2.5.1 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
3 VESICULAR STOMATITIS (VS) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Player
3.1.1 Global Vesicular Stomatitis (VS) Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Vesicular Stomatitis (VS) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VESICULAR STOMATITIS (VS) THERAPEUTICS BY REGION
4.1 Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025)
4.2 Global Vesicular Stomatitis (VS) Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2020-2025)
4.4 APAC Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2020-2025)
4.5 Europe Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
5.2 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025)
5.3 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025)
6.2 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025)
6.3 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
7.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025)
7.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VESICULAR STOMATITIS (VS) THERAPEUTICS MARKET FORECAST
10.1 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.3 APAC Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.4 Europe Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Forecast
10.2 Americas Vesicular Stomatitis (VS) Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.2.2 Canada Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.2.3 Mexico Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.2.4 Brazil Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3 APAC Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2026-2031)
10.3.1 China Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.2 Japan Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3.3 Korea Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3.4 Southeast Asia Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3.5 India Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.3.6 Australia Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4 Europe Vesicular Stomatitis (VS) Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4.2 France Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4.3 UK Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4.4 Italy Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.4.5 Russia Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.5.2 South Africa Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.5.3 Israel Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.5.4 Turkey Market Vesicular Stomatitis (VS) Therapeutics Forecast
10.6 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Type (2026-2031)
10.7 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Vesicular Stomatitis (VS) Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Information
11.1.2 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product Offered
11.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Boehringer Ingelheim Main Business Overview
11.1.5 Boehringer Ingelheim Latest Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Vesicular Stomatitis (VS) Therapeutics Product Offered
11.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Merck & Co Main Business Overview
11.2.5 Merck & Co Latest Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Vesicular Stomatitis (VS) Therapeutics Product Offered
11.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Zoetis Main Business Overview
11.3.5 Zoetis Latest Developments
11.4 Vedco
11.4.1 Vedco Company Information
11.4.2 Vedco Vesicular Stomatitis (VS) Therapeutics Product Offered
11.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Vedco Main Business Overview
11.4.5 Vedco Latest Developments
11.5 Elanco
11.5.1 Elanco Company Information
11.5.2 Elanco Vesicular Stomatitis (VS) Therapeutics Product Offered
11.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Elanco Main Business Overview
11.5.5 Elanco Latest Developments
11.6 Ceva Sant? Animale
11.6.1 Ceva Sant? Animale Company Information
11.6.2 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Product Offered
11.6.3 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Ceva Sant? Animale Main Business Overview
11.6.5 Ceva Sant? Animale Latest Developments
11.7 Vibrac
11.7.1 Vibrac Company Information
11.7.2 Vibrac Vesicular Stomatitis (VS) Therapeutics Product Offered
11.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Vibrac Main Business Overview
11.7.5 Vibrac Latest Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Company Information
11.8.2 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product Offered
11.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Vetoquinol Main Business Overview
11.8.5 Vetoquinol Latest Developments
11.9 IDEXX Laboratories
11.9.1 IDEXX Laboratories Company Information
11.9.2 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product Offered
11.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 IDEXX Laboratories Main Business Overview
11.9.5 IDEXX Laboratories Latest Developments
11.10 Covetrus
11.10.1 Covetrus Company Information
11.10.2 Covetrus Vesicular Stomatitis (VS) Therapeutics Product Offered
11.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Covetrus Main Business Overview
11.10.5 Covetrus Latest Developments
11.11 Neogen
11.11.1 Neogen Company Information
11.11.2 Neogen Vesicular Stomatitis (VS) Therapeutics Product Offered
11.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Neogen Main Business Overview
11.11.5 Neogen Latest Developments
11.12 Grand Pharmaceutical Group
11.12.1 Grand Pharmaceutical Group Company Information
11.12.2 Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Product Offered
11.12.3 Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Grand Pharmaceutical Group Main Business Overview
11.12.5 Grand Pharmaceutical Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Vesicular Stomatitis (VS) Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Symptomatic Medications
Table 4. Major Players of Vaccination
Table 5. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Vesicular Stomatitis (VS) Therapeutics Key Players Head office and Products Offered
Table 14. Vesicular Stomatitis (VS) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Vesicular Stomatitis (VS) Therapeutics
Table 39. Key Market Challenges & Risks of Vesicular Stomatitis (VS) Therapeutics
Table 40. Key Industry Trends of Vesicular Stomatitis (VS) Therapeutics
Table 41. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Boehringer Ingelheim Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 46. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 47. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Boehringer Ingelheim Main Business
Table 49. Boehringer Ingelheim Latest Developments
Table 50. Merck & Co Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 51. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 52. Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Merck & Co Main Business
Table 54. Merck & Co Latest Developments
Table 55. Zoetis Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 56. Zoetis Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 57. Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Zoetis Main Business
Table 59. Zoetis Latest Developments
Table 60. Vedco Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 61. Vedco Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 62. Vedco Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Vedco Main Business
Table 64. Vedco Latest Developments
Table 65. Elanco Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 66. Elanco Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 67. Elanco Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Elanco Main Business
Table 69. Elanco Latest Developments
Table 70. Ceva Sant? Animale Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 71. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 72. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Ceva Sant? Animale Main Business
Table 74. Ceva Sant? Animale Latest Developments
Table 75. Vibrac Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 76. Vibrac Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 77. Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Vibrac Main Business
Table 79. Vibrac Latest Developments
Table 80. Vetoquinol Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 81. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 82. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Vetoquinol Main Business
Table 84. Vetoquinol Latest Developments
Table 85. IDEXX Laboratories Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 86. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 87. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. IDEXX Laboratories Main Business
Table 89. IDEXX Laboratories Latest Developments
Table 90. Covetrus Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 91. Covetrus Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 92. Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Covetrus Main Business
Table 94. Covetrus Latest Developments
Table 95. Neogen Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 96. Neogen Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 97. Neogen Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Neogen Main Business
Table 99. Neogen Latest Developments
Table 100. Grand Pharmaceutical Group Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 101. Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 102. Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Grand Pharmaceutical Group Main Business
Table 104. Grand Pharmaceutical Group Latest Developments
Table 1. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Vesicular Stomatitis (VS) Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Symptomatic Medications
Table 4. Major Players of Vaccination
Table 5. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Vesicular Stomatitis (VS) Therapeutics Key Players Head office and Products Offered
Table 14. Vesicular Stomatitis (VS) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Vesicular Stomatitis (VS) Therapeutics
Table 39. Key Market Challenges & Risks of Vesicular Stomatitis (VS) Therapeutics
Table 40. Key Industry Trends of Vesicular Stomatitis (VS) Therapeutics
Table 41. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Boehringer Ingelheim Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 46. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 47. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Boehringer Ingelheim Main Business
Table 49. Boehringer Ingelheim Latest Developments
Table 50. Merck & Co Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 51. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 52. Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Merck & Co Main Business
Table 54. Merck & Co Latest Developments
Table 55. Zoetis Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 56. Zoetis Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 57. Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Zoetis Main Business
Table 59. Zoetis Latest Developments
Table 60. Vedco Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 61. Vedco Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 62. Vedco Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Vedco Main Business
Table 64. Vedco Latest Developments
Table 65. Elanco Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 66. Elanco Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 67. Elanco Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Elanco Main Business
Table 69. Elanco Latest Developments
Table 70. Ceva Sant? Animale Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 71. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 72. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Ceva Sant? Animale Main Business
Table 74. Ceva Sant? Animale Latest Developments
Table 75. Vibrac Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 76. Vibrac Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 77. Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Vibrac Main Business
Table 79. Vibrac Latest Developments
Table 80. Vetoquinol Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 81. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 82. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Vetoquinol Main Business
Table 84. Vetoquinol Latest Developments
Table 85. IDEXX Laboratories Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 86. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 87. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. IDEXX Laboratories Main Business
Table 89. IDEXX Laboratories Latest Developments
Table 90. Covetrus Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 91. Covetrus Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 92. Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Covetrus Main Business
Table 94. Covetrus Latest Developments
Table 95. Neogen Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 96. Neogen Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 97. Neogen Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Neogen Main Business
Table 99. Neogen Latest Developments
Table 100. Grand Pharmaceutical Group Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 101. Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 102. Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Grand Pharmaceutical Group Main Business
Table 104. Grand Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Vesicular Stomatitis (VS) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Vesicular Stomatitis (VS) Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Vesicular Stomatitis (VS) Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Vesicular Stomatitis (VS) Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type in 2024
Figure 10. Vesicular Stomatitis (VS) Therapeutics in Veterinary Hospitals
Figure 11. Global Vesicular Stomatitis (VS) Therapeutics Market: Veterinary Hospitals (2020-2025) & ($ millions)
Figure 12. Vesicular Stomatitis (VS) Therapeutics in Veterinary Clinics
Figure 13. Global Vesicular Stomatitis (VS) Therapeutics Market: Veterinary Clinics (2020-2025) & ($ millions)
Figure 14. Vesicular Stomatitis (VS) Therapeutics in Retail Pharmacies
Figure 15. Global Vesicular Stomatitis (VS) Therapeutics Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Vesicular Stomatitis (VS) Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Vesicular Stomatitis (VS) Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Vesicular Stomatitis (VS) Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Vesicular Stomatitis (VS) Therapeutics Value Market Share by Country in 2024
Figure 24. United States Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 1. Vesicular Stomatitis (VS) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Vesicular Stomatitis (VS) Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Vesicular Stomatitis (VS) Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Vesicular Stomatitis (VS) Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type in 2024
Figure 10. Vesicular Stomatitis (VS) Therapeutics in Veterinary Hospitals
Figure 11. Global Vesicular Stomatitis (VS) Therapeutics Market: Veterinary Hospitals (2020-2025) & ($ millions)
Figure 12. Vesicular Stomatitis (VS) Therapeutics in Veterinary Clinics
Figure 13. Global Vesicular Stomatitis (VS) Therapeutics Market: Veterinary Clinics (2020-2025) & ($ millions)
Figure 14. Vesicular Stomatitis (VS) Therapeutics in Retail Pharmacies
Figure 15. Global Vesicular Stomatitis (VS) Therapeutics Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Vesicular Stomatitis (VS) Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Vesicular Stomatitis (VS) Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Vesicular Stomatitis (VS) Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Vesicular Stomatitis (VS) Therapeutics Value Market Share by Country in 2024
Figure 24. United States Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Size 2026-2031 ($ millions)
More Publications
Global API Contract Manufacturing Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2025
102 pages
Global Skin Antiseptic Products Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
128 pages
